Education
About Us
Working with TipRanks
Follow Us
CPAI - AI Analysis
Top Page
Counterpoint Quantitative Equity ETF (CPAI)
Rating:66Neutral
Price Target:
$43.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Micron and Kinross Gold, have delivered strong year-to-date performance, supporting overall returns.
Sector Diversification
The fund is spread across multiple sectors, including Technology, Consumer Defensive, and Health Care, reducing reliance on any single industry.
Solid Year-to-Date Performance
The ETF has shown strong year-to-date growth, indicating positive momentum in its portfolio.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with over 97% exposure, limiting diversification across global markets.
Mixed Performance Among Holdings
Some top holdings, such as Vestis Corporation and AMN Healthcare Services, have underperformed, potentially dragging on overall returns.
Relatively High Expense Ratio
The ETF charges a higher expense ratio compared to many passive funds, which could reduce net returns for investors.
CPAI vs. SPDR S&P 500 ETF (SPY)
AUM127.36M
RegionNorth America
Expense Ratio0.75%
Beta1.04
IssuerCounterpoint
Inception DateNov 28, 2023
Dividend Yield0.36%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume29,200
30 Day Avg. Volume13,743
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.84Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
CPAI Summary
The Counterpoint Quantitative Equity ETF (CPAI) is a fund that gives investors access to a wide range of U.S. companies across different sizes and industries. It includes well-known names like Micron and Albertsons Companies, as well as many others from sectors such as technology, healthcare, and consumer goods. This ETF is designed for those who want a balanced mix of growth and value stocks, making it a good choice for long-term growth and diversification. However, new investors should know that its performance can go up and down with the overall U.S. stock market, so it carries the risk of market volatility.
How much will it cost me?The Counterpoint Quantitative Equity ETF (CPAI) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is actively managed, using a quantitative approach to select stocks rather than simply tracking an index.
What would affect this ETF?The Counterpoint Quantitative Equity ETF (CPAI), with its focus on the U.S. market and diverse sector exposure, could benefit from strong growth in technology and healthcare sectors, driven by innovation and increased demand. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact consumer spending and cyclical industries. Regulatory changes or geopolitical tensions affecting North America could also influence the ETF's performance.
CPAI Top 10 Holdings
The Counterpoint Quantitative Equity ETF (CPAI) leans heavily into technology, with names like Micron and Ciena driving performance thanks to strong earnings and bullish momentum. Healthcare stocks like Aveanna and AMN Healthcare Services are showing mixed results, with Aveanna rising on positive technical indicators while AMN struggles with declining revenue. Meanwhile, Vestis Corporation is dragging the fund, grappling with financial challenges and negative earnings. With a clear focus on U.S. equities and a tech-heavy tilt, CPAI offers growth potential but faces headwinds from weaker performers in healthcare and industrials.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Micron | 2.73% | $3.44M | $251.44B | 124.80% | 78 Outperform | |
| Ciena | 2.61% | $3.29M | $26.65B | 197.53% | 70 Outperform | |
| Garrett Motion | 2.51% | $3.17M | $3.28B | 126.78% | 71 Outperform | |
| Cardinal Health | 2.44% | $3.07M | $45.10B | 74.94% | 65 Neutral | |
| Delek US Holdings | 2.39% | $3.02M | $2.31B | 145.56% | 50 Neutral | |
| Western Digital | 2.38% | $3.00M | $47.35B | 111.50% | 78 Outperform | |
| Seagate Tech | 2.34% | $2.95M | $57.15B | 167.34% | 67 Neutral | |
| Vestis Corporation | 2.32% | $2.92M | $675.02M | -62.13% | 54 Neutral | |
| Par Pacific Holdings | 2.28% | $2.88M | $2.05B | 161.68% | 52 Neutral | |
| Corning | 2.24% | $2.82M | $77.34B | 89.70% | 77 Outperform |
CPAI Technical Analysis
Positive
―
Price Trends
38.64
Positive
37.34
Positive
35.86
Positive
Market Momentum
0.31
Positive
52.12
Neutral
61.11
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CPAI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.38, equal to the 50-day MA of 38.64, and equal to the 200-day MA of 35.86, indicating a bullish trend. The MACD of 0.31 indicates Positive momentum. The RSI at 52.12 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CPAI.
CPAI Peer Comparison
Comparison Results
Performance Comparison
CPAI
Counterpoint Quantitative Equity ETF
39.40
6.05
18.14%
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents